GLF
BMY icon

Groupe la Francaise’s Bristol-Myers Squibb BMY Stock Holding History

Groupe la Francaise’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4K Buy
590
+501
+563% +$28.8K ﹤0.01% 441
2026
Q1 		$4.61K Hold
89
– – ﹤0.01% 437
2025
Q4 		$4.05K Sell
89
-1,720
-95% -$82.7K ﹤0.01% 442
2025
Q3 		$80.9K Sell
1,809
-250
-12% -$11.7K ﹤0.01% 463
2025
Q2 		$94.9K Buy
2,059
+1,970
+2,213% +$96.7K ﹤0.01% 395
2025
Q1 		$4.81K Hold
89
– – ﹤0.01% 427
2024
Q4 		$3K Buy
+89
New +$4.97K ﹤0.01% 325

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Groupe la Francaise's BMY Position: Q2 2026 in Review

Groupe la Francaise increased its Bristol-Myers Squibb (BMY) stake by 563% in Q2 2026, buying an estimated $28.8K and bringing the position to 590 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Groupe la Francaise first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $94.9K in Q2 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Groupe la Francaise held 590 shares of Bristol-Myers Squibb worth $33.4K as of Q2 2026.
  • Groupe la Francaise bought 501 Bristol-Myers Squibb shares in Q2 2026, an estimated $28.8K.
  • Bristol-Myers Squibb made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #441 holding.
  • Groupe la Francaise first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Groupe la Francaise's Bristol-Myers Squibb position peaked at $94.9K in Q2 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.